Skip to main content
    I

    Iovance Biotherapeutics Inc (IOVA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.53
    -0.02 (-0.26%)

    Market Cap: $3.59B

    Last updated: Nov 17, 2026 at 4:35 PM ET

    Iovance Biotherapeutics Inc (IOVA) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Iovance Biotherapeutics (IOVA) has a latest price of $7.53 on Nov 17, 2026, 51.0% below its 52-week high of $15.37. Its price rose 204.9% over the past 12 months. The month-end price rose 35.7% over the 10 years through Oct 2026, a compound annual rate of 3.1%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $46.40 in Dec 2020 and its lowest $1.72 in Jun 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart IOVA with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for IOVA.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 5.8%, and over 6 months it rose 117.6%. The month-end price rose 122.0% over the 3 years through Oct 2026, a compound annual rate of 30.5%.

    PeriodChange
    1 month-47.0%
    3 months-5.8%
    6 months+117.6%
    12 months+204.9%
    12 months, with dividends+204.9%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+122.0%+30.5%
    5 years-65.1%-19.0%
    10 years+35.7%+3.1%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2019, when the price rose 212.8%, and its weakest was 2022, when it fell 66.5%.

    YearCloseChange
    2026 through Oct 2026$8.48+210.6%
    2025$2.73-63.1%
    2024$7.40-9.0%
    2023$8.13+27.2%
    2022$6.39-66.5%
    2021$19.09-58.9%
    2020$46.40+67.6%
    2019$27.68+212.8%
    2018$8.85+10.6%
    2017$8.00+15.1%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 33.3% below its 50-day average of $11.29 and 22.2% above its 200-day average of $6.16.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$7.53
    52-week high$15.37-51.0%
    52-week low$2.08+262.0%
    50-day average$11.29-33.3%
    200-day average$6.16+22.2%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 90.5%.

    MeasureValue
    1-year beta1.63
    Largest fall, 1 year-49.3%
    Largest fall, 3 years-90.5%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About IOVA

    What is IOVA's 1-year price change?

    Iovance Biotherapeutics's price rose 204.9% over the past 12 months. With dividends included, the 12-month total return was 204.9%.

    What is IOVA's 5-year price change?

    Iovance Biotherapeutics's month-end price fell 65.1% over the 5 years through Oct 2026, a compound annual decline of 19.0%. These figures leave out dividends.

    What is IOVA's 52-week high and low?

    Iovance Biotherapeutics's 52-week high is $15.37 and its 52-week low is $2.08. Its latest price of $7.53 on Nov 17, 2026 is 51.0% below the high.

    What is IOVA's beta?

    Iovance Biotherapeutics's 1-year beta against the S&P 500 is 1.63, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 49.3%.

    Is the IOVA chart free?

    Yes. Advanced Charting for IOVA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.